Key Pharmaceuticals赞助的临床试验
总计20073个结果
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., Belgium完全的药代动力学 | 晚期恶性肿瘤 | 实体恶性肿瘤 | 蛋白激酶抑制剂 | 最大耐受剂量 | 抗肿瘤方案 | 临床试验,第一阶段
-
Institut BergoniéBristol-Myers Squibb; Amgen; Aventis Pharmaceuticals; Sanofi-Synthelabo; Chugai Pharmaceutical完全的消化系统疾病 | 淋巴瘤 | 卵巢疾病 | 肺病 | 膀胱疾病 | 前列腺疾病法国
-
Escoles Universitaries GimbernatUniversidad Rey Juan Carlos招聘中
-
Peking Union Medical College HospitalNational Key Technologies R&D Program for the 13th Five-year Plan; National Key Technologies... 和其他合作者完全的
-
Keya MedicalMedical University of South Carolina完全的
-
University of California, Los AngelesDey, L.P.撤销
-
Foresee Pharmaceuticals Co., Ltd.QPS Holdings LLC; Changchun GeneScience Pharmaceutical Co., Ltd.招聘中
-
Henan Cancer HospitalQilu Pharmaceutical Co., Ltd.; Beijing Biostar Pharmaceuticals Co., Ltd.尚未招聘HER-2 阴性乳腺癌
-
Ferring PharmaceuticalsFerring Pharmaceuticals Korea, Ltd.完全的
-
EMET Pharmaceuticals, LLCEagle Pharmaceuticals, Inc.完全的
-
Regeneron Pharmaceuticals尚未招聘
-
Regeneron Pharmaceuticals尚未招聘黑色素瘤 | 晚期实体瘤 | 透明细胞肾细胞癌 (ccRCC)
-
Regeneron Pharmaceuticals尚未招聘视力障碍 | 糖尿病性黄斑水肿 (DME) | 新生血管性年龄相关性黄斑变性 (nAMD) | 湿性年龄相关性黄斑变性 (AMD)
-
Ferring Pharmaceuticals尚未招聘
-
Regeneron Pharmaceuticals尚未招聘肌萎缩侧索硬化症 (ALS) | 超氧化物歧化酶 1 (SOD1) 基因突变
-
Regeneron Pharmaceuticals尚未招聘
-
Regeneron Pharmaceuticals尚未招聘
-
Regeneron Pharmaceuticals招聘中
-
Regeneron Pharmaceuticals尚未招聘
-
Regeneron Pharmaceuticals招聘中
-
Regeneron Pharmaceuticals尚未招聘意义未明的单克隆丙种球蛋白病 (MGUS) | 冒烟型多发性骨髓瘤 (SMM)
-
Intercept Pharmaceuticals尚未招聘
-
Dizal Pharmaceuticals招聘中